Bridge Formulation Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 14-12-2024
- Paid Up Capital ₹ 1.00 M
as on 14-12-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -12.88%
(FY 2020)
- Profit -8583.25%
(FY 2020)
- Ebitda -4653.57%
(FY 2020)
- Net Worth -608.24%
(FY 2020)
- Total Assets -46.03%
(FY 2020)
About Bridge Formulation
The Corporate was formerly known as Abhyudaya Educational Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Srivastava and Nirmal Jyoti serve as directors at the Company.
- CIN/LLPIN
U24100UP2010PTC041468
- Company No.
041468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Bridge Formulation Private Limited offer?
Bridge Formulation Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Allopathic Cough Syrup, Nutraceuticals & Dietary Supplements, Mineral Supplement, Antacid Drugs, Anti Ulcer Drugs.
Who are the key members and board of directors at Bridge Formulation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Srivastava  | Director | 25-Sep-2022 | Current |
| Nirmal Jyoti | Director | 10-May-2013 | Current |
Financial Performance of Bridge Formulation.
Bridge Formulation Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.88% decrease. The company also saw a substantial fall in profitability, with a 8583.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 608.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bridge Formulation?
In 2020, Bridge Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bridge Formulation?
Bridge Formulation has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bridge Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bridge Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
